作者
Edward M. Schaeffer,Sandy Srinivas,Nabil Adra,Yi An,Rhonda L. Bitting,Brian F. Chapin,Heather H. Cheng,Anthony V. D’Amico,Neil B. Desai,Tanya B. Dorff,James A. Eastham,Thomas A. Farrington,Xīn Gào,Shilpa Gupta,Thomas Guzzo,Joseph E. Ippolito,R. Jeffrey Karnes,Michael Kuettel,Joshua M. Lang,Tamara L. Lotan,Rana R. McKay,Todd M. Morgan,Julio M. Pow‐Sang,Robert E. Reiter,Mack Roach,Tyler P. Robin,Stan Rosenfeld,Ahmad Shabsigh,Daniel E. Spratt,Russell Z. Szmulewitz,Benjamin A. Teply,Jonathan D. Tward,Richard K. Valicenti,J.K. Wong,Jenna Snedeker,Deborah A. Freedman-Cass
摘要
The NCCN Guidelines for Prostate Cancer include recommendations for staging and risk assessment after a prostate cancer diagnosis and for the care of patients with localized, regional, recurrent, and metastatic disease. These NCCN Guidelines Insights summarize the panel's discussions for the 2024 update to the guidelines with regard to initial risk stratification, initial management of very-low-risk disease, and the treatment of nonmetastatic recurrence.
不配.
个性的紫菜
彭于彦祖
薰硝壤
浅尝离白
yupaopao
ShowMaker
Singularity
好困
Cloud
pcr163
iNk
shinysparrow
Yziii
乐乐乐乐乐乐
kento
元谷雪
爱静静
寻道图强
dxwy
皖公网安备34019202002308
